Welcome to our dedicated page for DGDM news (Ticker: DGDM), a resource for investors and traders seeking the latest updates and insights on DGDM stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DGDM's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DGDM's position in the market.
Digital Development Partners, Inc. (DGDM) has secured exclusive global distribution rights for MiteXstream, a plant-based biopesticide effective against spider mites. This agreement includes an impressive 80% reduction in royalty rates, enhancing the company's financial potential. MiteXstream is registered with the EPA and enables cannabis growers to treat plants without damaging them, even close to harvest time. Digital Development anticipates that this partnership will significantly bolster its position as a major innovator in the cannabis industry.